Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: KemPharm Q1 Earnings

KemPharm (NASDAQ:KMPH) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings KemPharm reported in-line EPS of $-0.05 versus an estimate of $-0.05.
byBenzinga Insights
May 12, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

KemPharm (NASDAQ:KMPH) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:05 PM.

Here’s what investors need to know about the announcement.

Earnings

KemPharm reported in-line EPS of $-0.05 versus an estimate of $-0.05.

Revenue was down $8.13 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 5.45% drop in the share price the next day.

Here’s a look at KemPharm’s past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.07 -0.07 0.22 -0.17
EPS Actual -0.08 -0.06 -0.40 -1.61
Revenue Estimate 2.23M 2.18M 12.10M 2.10M
Revenue Actual 2.60M 1.97M 11.99M 12.10M

To track all earnings releases for KemPharm visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Outlook For OneSpan

By Benzinga Insights
Today, 3:03 PM
OneSpan (NASDAQ:OSPN) is set to give its latest quarterly earnings report on Tuesday, 2022-02-22. Here's what investors need to know before the announcement. Analysts estimate that OneSpan will report an earnings per share (EPS) of $-0.08.

OSPN